Vascular

Robert A. Vogel, MD
Herbert Berger Professor of Medicine; head, Division of Cardiology; Associate Chairman of Medicine for Clinical Affairs; co-director, Center for Vascular Biology and Hypertension, University of Maryland Medical Center, Baltimore

Address: Robert A. Vogel, MD, University of Maryland Medical Center, 22 South Greene Street, Baltimore, Maryland 21201

Robert A. Vogel, MD
Herbert Berger Professor of Medicine; head, Division of Cardiology; Associate Chairman of Medicine for Clinical Affairs; co-director, Center for Vascular Biology and Hypertension, University of Maryland Medical Center, Baltimore

Address: Robert A. Vogel, MD, University of Maryland Medical Center, 22 South Greene Street, Baltimore, Maryland 21201

Robert A. Vogel, MD
Herbert Berger Professor of Medicine; head, Division of Cardiology; Associate Chairman of Medicine for Clinical Affairs; co-director, Center for Vascular Biology and Hypertension, University of Maryland Medical Center, Baltimore

Address: Robert A. Vogel, MD, University of Maryland Medical Center, 22 South Greene Street, Baltimore, Maryland 21201

Alejandro C. Arroliga, MD
Director, Medical Intensive Care Unit, Department of Pulmonary and Critical Care Medicine, Cleveland Clinic

Raed A. Dweik, MD
Department of Pulmonary and Critical Care Medicine, Cleveland Clinic

F. J. Takao Kaneko, MD
Department of Critical Care Medicine, Central Military Hospital, Mexico City, Mexico

Serpil C. Erzurum, MD
Department of Pulmonary and Critical Care Medicine, Cleveland Clinic

Address: Alejandro C. Arroliga, MD, Medical Intensive Care Unit, G62, Cleveland Clinic, 9500 Euclid Avenue, Cleveland OH 44195; [email protected]

Alejandro C. Arroliga, MD
Director, Medical Intensive Care Unit, Department of Pulmonary and Critical Care Medicine, Cleveland Clinic

Raed A. Dweik, MD
Department of Pulmonary and Critical Care Medicine, Cleveland Clinic

F. J. Takao Kaneko, MD
Department of Critical Care Medicine, Central Military Hospital, Mexico City, Mexico

Serpil C. Erzurum, MD
Department of Pulmonary and Critical Care Medicine, Cleveland Clinic

Address: Alejandro C. Arroliga, MD, Medical Intensive Care Unit, G62, Cleveland Clinic, 9500 Euclid Avenue, Cleveland OH 44195; [email protected]

Alejandro C. Arroliga, MD
Director, Medical Intensive Care Unit, Department of Pulmonary and Critical Care Medicine, Cleveland Clinic

Raed A. Dweik, MD
Department of Pulmonary and Critical Care Medicine, Cleveland Clinic

F. J. Takao Kaneko, MD
Department of Critical Care Medicine, Central Military Hospital, Mexico City, Mexico

Serpil C. Erzurum, MD
Department of Pulmonary and Critical Care Medicine, Cleveland Clinic

Address: Alejandro C. Arroliga, MD, Medical Intensive Care Unit, G62, Cleveland Clinic, 9500 Euclid Avenue, Cleveland OH 44195; [email protected]

Matthew T. Roe, MD
Division of Cardiology, Duke Clinical Research Institute

Shelly K. Sapp, MS
Senior blostatistician, Cleveland Clinic Cardiovascular Coordinating Center

A. Michael Lincoff, MD
Director, Experiental Interventional Laboratory Department of Cardiology, Cleveland Clinic; Editor of Glycoprotein IIb/IIIa Inhibitors in Cardiovascular Diseases

Address: A. Michael Lincoff, MD, Department of Cardiology, Desk F25, Cleveland Clinic, 9500 Euclid Avenue, Cleveland, OH 44195; [email protected]

Matthew T. Roe, MD
Division of Cardiology, Duke Clinical Research Institute

Shelly K. Sapp, MS
Senior blostatistician, Cleveland Clinic Cardiovascular Coordinating Center

A. Michael Lincoff, MD
Director, Experiental Interventional Laboratory Department of Cardiology, Cleveland Clinic; Editor of Glycoprotein IIb/IIIa Inhibitors in Cardiovascular Diseases

Address: A. Michael Lincoff, MD, Department of Cardiology, Desk F25, Cleveland Clinic, 9500 Euclid Avenue, Cleveland, OH 44195; [email protected]

Matthew T. Roe, MD
Division of Cardiology, Duke Clinical Research Institute

Shelly K. Sapp, MS
Senior blostatistician, Cleveland Clinic Cardiovascular Coordinating Center

A. Michael Lincoff, MD
Director, Experiental Interventional Laboratory Department of Cardiology, Cleveland Clinic; Editor of Glycoprotein IIb/IIIa Inhibitors in Cardiovascular Diseases

Address: A. Michael Lincoff, MD, Department of Cardiology, Desk F25, Cleveland Clinic, 9500 Euclid Avenue, Cleveland, OH 44195; [email protected]

Donald G. Vidt, MD
Senior physician, Department of Nephrology and Hypertension, Cleveland Clinic; Professor of Internal Medicine, Ohio State University; member, Sixth Joint National Committee on Detection, Evaluation, and Treatment of High Blood Pressure

Donald G. Vidt, MD
Senior physician, Department of Nephrology and Hypertension, Cleveland Clinic; Professor of Internal Medicine, Ohio State University; member, Sixth Joint National Committee on Detection, Evaluation, and Treatment of High Blood Pressure

Donald G. Vidt, MD
Senior physician, Department of Nephrology and Hypertension, Cleveland Clinic; Professor of Internal Medicine, Ohio State University; member, Sixth Joint National Committee on Detection, Evaluation, and Treatment of High Blood Pressure

Norman S. Ryan, MD
Chicago, Illinois, received via e-mail

Norman S. Ryan, MD
Chicago, Illinois, received via e-mail

Norman S. Ryan, MD
Chicago, Illinois, received via e-mail

Sorin J. Brener, MD
Department of Cardiology, Cleveland Clinic; Assistant Professor of Medicine, Ohio State University; principal investigator in the RAPPORT and INTRO AMI studies, which designed new strategies for patients with heart attacks

Address: Sorin J. Brener, MD, Department of Cardiology, F25, Cleveland Clinic, 9500 Euclid Avenue, Cleveland, OH 44195

Sorin J. Brener, MD
Department of Cardiology, Cleveland Clinic; Assistant Professor of Medicine, Ohio State University; principal investigator in the RAPPORT and INTRO AMI studies, which designed new strategies for patients with heart attacks

Address: Sorin J. Brener, MD, Department of Cardiology, F25, Cleveland Clinic, 9500 Euclid Avenue, Cleveland, OH 44195

Sorin J. Brener, MD
Department of Cardiology, Cleveland Clinic; Assistant Professor of Medicine, Ohio State University; principal investigator in the RAPPORT and INTRO AMI studies, which designed new strategies for patients with heart attacks

Address: Sorin J. Brener, MD, Department of Cardiology, F25, Cleveland Clinic, 9500 Euclid Avenue, Cleveland, OH 44195

James Young, MD
Head, Section of Heart Failure and Cardiac Transplant Medicine, Department of Cardiology Cleveland Clinic; co-editor, Consensus Recommendations for the Management of Chronic Heart Failure

James Young, MD
Head, Section of Heart Failure and Cardiac Transplant Medicine, Department of Cardiology Cleveland Clinic; co-editor, Consensus Recommendations for the Management of Chronic Heart Failure

James Young, MD
Head, Section of Heart Failure and Cardiac Transplant Medicine, Department of Cardiology Cleveland Clinic; co-editor, Consensus Recommendations for the Management of Chronic Heart Failure

Mina K. Chung, MD
Department of Cardiology, Section of Cardiac Electrophysiology and Pacing, Cleveland Clinic

Mina K. Chung, MD
Department of Cardiology, Section of Cardiac Electrophysiology and Pacing, Cleveland Clinic

Mina K. Chung, MD
Department of Cardiology, Section of Cardiac Electrophysiology and Pacing, Cleveland Clinic